Can a gentle brain current silence voices that medication Can't?

NCT ID NCT04352569

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This trial tests whether transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique, can reduce auditory hallucinations in people with schizophrenia who haven't found relief from antipsychotic medications. Participants receive either real tDCS or a placebo (sham) stimulation, with two sessions per day for two weeks. The study measures changes in hallucination severity and overall symptoms to see if this approach could be a helpful addition to current treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS), a non-invasive brain stimulation technique
What this could lead to
If effective, tDCS could offer a new, non-drug option to reduce distressing auditory hallucinations in people with schizophrenia who haven't responded to antipsychotics.
What could go wrong
This is a small, early-stage trial, so results may not be conclusive or widely applicable. tDCS is generally safe but may cause mild discomfort or tingling at the stimulation site.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HALLUCINATIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hallucinations schizophrenia Schizophrenia, Treatment-Resistant treatment-refractory schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • unité de recherche clinique de l'E.P.S de Ville Evrard

    Neuilly-sur-Marne, 93332, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.